EMILY BRETON: Open Payments
NPI 1679950125 · MARSTONS MILLS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,223 in 133 payments from 18 companies in 2025. Trend: 2023 $2,594 · 2024 $2,340 · 2025 $2,223
Food & beverage: $2,213Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $687 |
| Novartis Pharmaceuticals Corporation | 12 | $256 |
| Janssen Biotech, Inc. | 14 | $245 |
| GENZYME CORPORATION | 6 | $121 |
| UCB, Inc. | 6 | $119 |
| LEO Pharma Inc. | 4 | $114 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $86 |
| STRATA Skin Sciences, Inc. | 4 | $80 |
| Organon LLC | 4 | $71 |
Products named: SKYRIZI, TREMFYA, COSENTYX, DUPIXENT, RINVOQ, Bimzelx, ADBRY, XTRAC.
Industry payments across MA — which companies pay providers there.
